Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
NEJM Dec 2025) 12 None (no approved label) MTC thyroid C-cell (rodent, human relevance unestablished) 28 None published None published Once weekly, subcutaneous Once weekly, subcutaneous US: late 2027 earliest (NDA Q4 2026 at soonest) 22 Already approved (US: 2022/2023/2024
Time zone changes may affect your injection schedule
At the same time, it can slow the movement of food through the intestines, which may lead to less frequent bowel movements
Eli Lilly is expected to file for FDA approval in 2026 following TRIUMPH-1 results
Your physician determines the dosing schedule based on your response and goals
Production Capacity and Supply Novo Nordisk filed for FDA approval early in 2025, but it has been preparing for this launch for years
